Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The peptide contacting gut tissues directly may produce benefits regardless of systemic absorption levels
Protein-forward, whole-food diets with a modest caloric deficit, combined with resistance training and adequate sleep, drive the same lipolysis pathways that AOD-9604 targets pharmacologically
C is the control group and B is the BPC-157-treated group
Scientists at Monash University in Australia developed AOD 9604 in the 1990s specifically as an anti-obesity treatment
fragment-specific activity review: PMC8724243 TB-4 / TB-500 product mislabeling documented bidirectional mislabeling between full-length TB-4 (43 aa) and the TB-500 fragment (residues 1723) in marketed peptide products: Esposito M et al
Pernicious Anemia: Lifelong Replacement Strategies Pernicious anemia makes it hard to absorb vitamin B12
